Literature DB >> 12818620

New approaches in vaccine development.

Claude Leclerc1.   

Abstract

In the last century, vaccines have been one of the most powerful tools for preventing infectious diseases. Smallpox has been eradicated and other diseases such as poliomyelitis or measles have been reduced to very low levels in many regions of the world. However, infectious diseases remain the leading cause of death worldwide. Thus, the development of vaccines to prevent diseases for which no vaccine currently exists such as AIDS or malaria as well as the improvement of efficacy and safety of existing vaccines remains a high priority. Achieving such ambitious goals in a near future will certainly require a strong modification of the methods that have been used so far to identify vaccine candidates. In particular, modern vaccinology could strongly benefit of the latest developments of molecular biology and immunology. Here, we will discuss some potential applications of the increasing knowledge of pathogen genomes as well as the immune system for the discovery of new antigenic targets and the development of new strategies of vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818620     DOI: 10.1016/S0147-9571(03)00018-3

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  10 in total

1.  The Role of Helicobacter pylori Proinflammatory Outer Membrane Protein and Propolis in Immunomodulation on U937 Macrophage Cell Model.

Authors:  Hengameh Soudi; Tahereh Falsafi; Sara Gharavi; Mohaddeseh Mahboubi
Journal:  Galen Med J       Date:  2020-12-08

2.  Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.

Authors:  Patrick Lacasse; Jérôme Denis; Réjean Lapointe; Denis Leclerc; Alain Lamarre
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

3.  Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Annamaria Jakab; Giorgia Clementi; Eva Borrás; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

4.  Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  Virol J       Date:  2012-03-14       Impact factor: 4.099

5.  B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines.

Authors:  Esther Blanco; Carolina Cubillos; Noelia Moreno; Juan Bárcena; Beatriz G de la Torre; David Andreu; Francisco Sobrino
Journal:  Clin Dev Immunol       Date:  2013-12-03

6.  A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.

Authors:  Yinli Xie; Peng Gao; Zhiyong Li
Journal:  Biomed Res Int       Date:  2016-07-10       Impact factor: 3.411

7.  Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle.

Authors:  I Soria; V Quattrocchi; C Langellotti; M Pérez-Filgueira; J Pega; V Gnazzo; S Romera; J Schammas; D Bucafusco; S Di Giacomo; Beatriz G de la Torre; D Andreu; F Sobrino; E Blanco; P Zamorano
Journal:  J Immunol Res       Date:  2018-04-18       Impact factor: 4.818

8.  Phytochemical Constituents of Propolis Flavonoid, Immunological Enhancement, and Anti-porcine Parvovirus Activities Isolated From Propolis.

Authors:  Xia Ma; ZhenHuan Guo; Yana Li; Kun Yang; Xianghui Li; Yonglu Liu; Zhiqiang Shen; Li Zhao; Zhiqiang Zhang
Journal:  Front Vet Sci       Date:  2022-04-08

9.  MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.

Authors:  Diogo Oliveira-Maciel; Júlio Souza Dos-Santos; Gabriel Oliveira-Silva; Mirian França de Mello; Alessandra Marcia da Fonseca-Martins; Monique Pacheco Duarte Carneiro; Tadeu Diniz Ramos; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Microorganisms       Date:  2021-06-11

10.  Identification of Molecular Signatures from Different Vaccine Adjuvants in Chicken by Integrative Analysis of Microarray Data.

Authors:  Duk Kyung Kim; Kyeong Hye Won; Seung Hyun Moon; Hak-Kyo Lee
Journal:  Asian-Australas J Anim Sci       Date:  2015-04-06       Impact factor: 2.509

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.